Onconetix (ONCO) Other Non-Current Assets (2022 - 2024)
Onconetix (ONCO) posted quarterly Other Non-Current Assets of $56000.0 for Q2 2024, up 0.9% year-over-year from $55499.0 in Q3 2023, and up 618.69% quarter-over-quarter from $7792.0 in Q1 2024.
Onconetix (ONCO) Other Non-Current Assets (2022 - 2024) Analysis & Trends
Onconetix (ONCO) has reported Other Non-Current Assets for 3 consecutive years, with $56000.0 the latest figure, recorded in Q2 2024.
- In Q2 2024, Other Non-Current Assets rose 0.9% year-over-year to $56000.0; the TTM figure through Jun 2024 stood at $56000.0 (up 0.9% YoY), while the FY2023 annual figure was $17423.0, down 54.88% from the prior year.
- Other Non-Current Assets improved to $56000.0 in Q2 2024 per ONCO's latest filing, from $7792.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $87638.0 in Q1 2022 and bottomed at $7792.0 in Q1 2024.
- Historically, Other Non-Current Assets has averaged $47429.9 across 3 years, with a median of $55499.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets plunged 82.31% — and 2024, when it rose 0.9%.
- Onconetix's Other Non-Current Assets stood at $38617.0 in 2022, then plunged by 54.88% to $17423.0 in 2023, then soared by 221.41% to $56000.0 in 2024.
- Business Quant data shows ONCO's Other Non-Current Assets at $56000.0 in Q2 2024, $7792.0 in Q1 2024, and $17423.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | 225,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 56,000.00 |
| Mar 31, 2024 | 7,792.00 |
| Dec 31, 2023 | 17,423.00 |
| Sep 30, 2023 | 55,499.00 |
| Jun 30, 2023 | 55,499.00 |
| Mar 31, 2023 | 15,500.00 |
| Dec 31, 2022 | 38,617.00 |
| Sep 30, 2022 | 66,357.00 |
| Jun 30, 2022 | 73,974.00 |
| Mar 31, 2022 | 87,638.00 |